Completed
A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
NCT05059223
- Conditions
- Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
- Locations
-
- Clinical Research Site Alabaster, Alabama, United States
- Clinical Research Site Peoria, Arizona, United States
- Clinical Research Site Phoenix, Arizona, United States
- Clinical Research Site Redwood City, California, United States